Paralyzed man walks again after experimental drug trial triggers remarkable recovery
PositiveU.S News

In a groundbreaking development, a clinical trial of the NVG-291 peptide drug has shown remarkable results for spinal cord injury patients, with participant Larry Williams regaining his ability to walk and balance. This breakthrough not only highlights the potential of innovative treatments in restoring mobility but also brings hope to countless individuals affected by similar injuries. The success of this trial could pave the way for more advanced therapies, making a significant impact on the future of rehabilitation.
— Curated by the World Pulse Now AI Editorial System